Research News

Genetics and Parkinson’s – PRKN and PINK1 Genes

Monday, 10 September 2018

Learning about genetic risk factors for Parkinson’s can help scientists learn what goes wrong in the disease — even among those without those risk factors — and how they might fix it. Thanks to this strategy, treatments are now in…

Brain

Study’s Measure Parkinson’s Progression

Thursday, 29 March 2018

Two recent papers outline the progression of Parkinson’s disease (PD) movement or motor symptoms in distinct study populations. While these findings do not provide an absolute picture of how one person will progress with PD, the results may help researchers…

Freezing of Gait in Parkinson's disease

Brain Stimulation to Treat Freezing of Gait and Cognition

Monday, 19 March 2018

The sudden inability to move while walking, or feeling like your feet are stuck to the ground, is called “freezing of gait.” This symptom may arise as Parkinson’s disease (PD) progresses, and can lead to stumbling or falling. Unfortunately, current…

Lew Body Dementia

Seizure Medication May Help Lewy Body Dementia

Sunday, 28 January 2018

Lewy Body Dementia (LBD) is a type of dementia — a broad term for a disease of memory, thinking and/or social abilities that is severe enough to interfere with everyday activities. LBD also is a form of atypical parkinsonism, which…

caffeine may have a neuroprotective effect—meaning that people who are regular coffee drinkers are less likely to develop Parkinson's disease (PD)

Caffeine a Potential Marker for Parkinson’s

Monday, 15 January 2018

Millions of people reach for a caffeinated beverage each morning to jumpstart the day. Now, early research indicates that the stimulant that gets people moving also might help diagnose Parkinson’s disease (PD). A recent study published in Neurologyfound that people with Parkinson’s had…

Parkinson's research

LRRK2 Drug Trial Show Promising Results

Monday, 8 January 2018

Denali Therapeutics has announced positive results from its first-in-human LRRK2 inhibitor clinical trial. The trial concluded that the experimental treatment is safe, and showed a greater than 90 percent inhibition of LRRK2 activity at peak drug levels while lowered the LRRK2…

The Importance of Positive Thinking on your Health

Monday, 27 November 2017

We didn’t write the book on optimism, but we know the guy who did. In Always Looking Up: The Adventures of an Incurable Optimist, Michael J. Fox sets the example for living. “Your happiness grows in direct proportion to your acceptance and in inverse…

Fox Insight

Podcast -Learn more about Fox Insight

Monday, 27 November 2017

Fox Insight is an online clinical study where people with Parkinson’s disease and their loved ones share information that could transform the search for better treatments. Listen to this podcast More than 13,000 people have volunteered for The Michael J….

Parkinson's Therapeutics Conference

Parkinson’s Research Conference Spotlights Field-wide Advances

Monday, 6 November 2017

On October 30, more than 300 leaders in Parkinson’s disease (PD) research and business development gathered in NYC for The Michael J. Fox Foundation’s 11th Annual Parkinson’s Disease Therapeutics Conference. The event featured the latest in Parkinson’s drug development and…